Welcome to our Media Center

Here in our Media Center we offer corporate press releases and other useful information for business media.

Tweets

As part of our mission to drive technology to advance global health, we are changing the way new medicines and othe… twitter.com/i/web/status/1…
23 hours ago
The phase I trial for our precision oral anticoagulate (PROAC) VE-1902 has started. Verseon is now a clinical-stage… twitter.com/i/web/status/1…
13 Sep
Sweet 16! We want to thank everyone for their great support over the years. Here's hoping for at least another 16 m… twitter.com/i/web/status/1…
19 Jul
ICYMI: Today is global #HAEDAY! Folks around the globe have already taken more than 32 million steps in the HAE Glo… twitter.com/i/web/status/9…
16 May
Our latest data show that our oral DME drug candidates successfully reduce leakage and retinal thickness in preclin… twitter.com/i/web/status/9…
2 May

Proprietary Platform

Consistently designs novel drug candidates that are unlikely to be found using conventional methods

 

Drug Programs

Multiple therapeutic areas, all with unmet (or poorly met) medical needs